Madison Anne Martin, | |
103 Bennett Ln, Summerville, SC 29483-5422 | |
(248) 881-4218 | |
Not Available |
Full Name | Madison Anne Martin |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 103 Bennett Ln, Summerville, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053174250 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Madison Anne Martin, 103 Bennett Ln, Summerville, SC 29483-5422 Ph: (248) 881-4218 | Madison Anne Martin, 103 Bennett Ln, Summerville, SC 29483-5422 Ph: (248) 881-4218 |
News Archive
Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis.
A UCLA-led study of HIV-positive women who were sexually abused as children has found that the more severe their past trauma, the greater their improvement in an intervention program designed to ease their psychological suffering.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).
Uveal melanoma, or UM, is a rare and deadly cancer of the eye, and the mortality rate has remained unimproved for 40 years. Half of the melanomas spread to other organs of the body, causing death in less than a year, so new treatments to preserve vision and prevent death are an urgent need.
› Verified 1 days ago